Ann: COVID-19 Investor Presentation, page-17

About 12 years.

Yes, it's common for a CR to be accompanied by a corporate presentation. Particularly when there's a retail component.

But it's uncommon for a a CR to accompany a corporate presentation. Over the last two years Resapp have done five presentations (excluding AGM presentations) and raised capital only once.

So while it's possible that a capital raising might be conducted – we are down to the last $3 million (3 quarters of normal funding) – there's nothing in this particular presentation that presages one. Nor is there anything in the results just released that would require a large injection of funds. The algorithm is already trained. Candidates will be easily available for a clinical trial. The testing required for the independent diagnosis is fast and inexpensive. Resapp already has a platform for delivering the product to individual users, corporations and medical practitioners.